Dr. Chabra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2600 N Oregon St
El Paso, TX 79902Phone+1 915-317-1660Fax+1 915-320-4848
Education & Training
- University of California (Irvine)Fellowship, Rheumatology, 2006 - 2008
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2002 - 2005
- College of Osteopathic Medicine of the PacificClass of 2002
Certifications & Licensure
- CA State License 2006 - 2026
- TX State License 2018 - 2026
- AZ State License 2004 - 2023
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2012
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 1 citationsSatisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab.Sanjay Chabra, Julie Birt, Rebecca Bolce, Jeffrey Lisse, William N Malatestinic
Advances in Therapy. 2024-04-01 - 16 citationsIxekizumab Citrate-Free Formulation: Results from Two Clinical Trials.Sanjay Chabra, B J Gill, Gaia Gallo, Danting Zhu, Celine Pitou
Advances in Therapy. 2022-06-01 - 39 citationsCervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging.Peter Y. Kim, Bradley J. Monk, Sanjay Chabra, Robert A. Burger, Steven A. Vasilev
Gynecologic Oncology. 1998-06-01
Press Mentions
- RINVOQ® (Upadacitinib) Has Remission Data, with or Without Methotrexate1-3August 1st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: